J. Suárez

发表

Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes.

J. Lis, Brian E. Schwartz, Zhuoyu Ni, 2004, Molecular cell.

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

Thomas S. Lin, M. Grever, J. Byrd, 2007, Blood.

P-TEFb Is Critical for the Maturation of RNA Polymerase II into Productive Elongation In Vivo

W. Webb, J. Lis, Jie Yao, 2007, Molecular and Cellular Biology.

Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol.

V. D’Agati, P. Nelson, I. Gelman, 2003, The Journal of antimicrobial chemotherapy.

high-risk chronic lymphocytic leukemia associated with marked clinical efficacy in refractory, genetically Flavopiridol administered using a pharmacologically derived schedule is

M. Grever, B. Rovin, N. Heerema, 2013 .

Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.

T. Merigan, M. Winters, J. Balzarini, 1999, The Journal of infectious diseases.

Characterizing patterns of drug‐taking behavior with a multiple drug regimen in an AIDS clinical trial

D. Katzenstein, L. Sheiner, P. Girard, 1998, AIDS.

Plenary paper Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia

M. Grever, J. Byrd, B. Rovin, 2006 .

Flavopiridol Administered as a Pharmacologically-Derived Schedule Demonstrates Marked Clinical Activity in Refractory, Genetically High Risk, Chronic Lymphocytic Leukemia (CLL).

M. Grever, J. Byrd, K. Blum, 2004 .

The extent of non‐adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker

S. Hammer, D. Katzenstein, H. Kastrissios, 1998, AIDS.